Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Zimmer Biomet Holdings, Inc., widely recognised as Zimmer Biomet, is a leading global medical technology company headquartered in the US with extensive operations across more than 100 countries. Formed through the merger of Zimmer (1927) and Biomet (1977) in 2015, the company boasts a rich heritage in advancing musculoskeletal healthcare.
Specialising in medical and precision instruments, Zimmer Biomet develops, manufactures, and markets an extensive portfolio of orthopaedic reconstruction products, including innovative hip and knee joint replacements. Their offerings further encompass surgical technologies, spine and dental products, and trauma solutions, all designed to alleviate pain and restore mobility worldwide.
As a trusted partner to healthcare professionals, Zimmer Biomet remains at the forefront of pioneering medical device innovation, consistently improving patient quality of life.
+12 vs industry average
Zimmer Biomet’s score of 44 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Zimmer Biomet, a US-headquartered company in the Medical, precision and optical instruments, watches and clocks industry, reported its 2025 Scope 1 emissions as 15,094,000 kg CO2e. Market-based Scope 2 emissions for 2025 were 22,101,000 kg CO2e, while location-based Scope 2 emissions stood at 98,022,000 kg CO2e. The total market-based Scope 1 and 2 emissions for 2025 were 37,195,000 kg CO2e. The company has not disclosed Scope 3 emissions data for 2025, specifically noting missing data for purchased goods and services.
Looking at previous years for Scope 1 and 2 market-based emissions, Zimmer Biomet reported:
Zimmer Biomet is committed to significant climate action. The company aims to reduce its absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 55% by 2030, using a 2017 base year. Additionally, Zimmer Biomet has committed to reducing its absolute Scope 3 GHG emissions from purchased goods and services by 15% by 2030, with a 2019 base year. These near-term targets are classified as consistent with a 1.5°C warming scenario by the Science Based Targets initiative (SBTi). Furthermore, Zimmer Biomet formally committed to the SBTi in September 2023 to achieve Net-Zero GHG emissions by 2050.
2030
55% reduction in Scope 1
Zimmer Biomet commits to reduce absolute scope 1 GHG emissions 55% by 2030 from a 2017 base year.
2030
55% reduction in Scope 2
Zimmer Biomet commits to reduce absolute scope 2 GHG emissions 55% by 2030 from a 2017 base year.
2030
15% reduction in scope 3 upstream
Zimmer Biomet also commits to reduce absolute scope 3 GHG emissions from purchased goods and services 15% by 2030 from a 2019 base year.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Zimmer Biomet’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more